These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30268042)

  • 1. Severe disease exacerbation in a patient with neuromyelitis optica spectrum disorder during treatment with dimethyl fumarate.
    Popiel M; Psujek M; Bartosik-Psujek H
    Mult Scler Relat Disord; 2018 Nov; 26():204-206. PubMed ID: 30268042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder.
    Yamout BI; Beaini S; Zeineddine MM; Akkawi N
    Mult Scler; 2017 Aug; 23(9):1297-1300. PubMed ID: 28391740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Relapses of Neuromyelitis Optica Spectrum Disorder During Treatment With Dimethyl Fumarate.
    Javadian N; Magrouni H; Ghaffarpour M; Ranji-Burachaloo S
    Clin Neuropharmacol; 2021 Jan-Feb 01; 44(1):21-22. PubMed ID: 33449476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected exacerbations following initiation of disease-modifying drugs in neuromyelitis optica spectrum disorder: Which factor is responsible, anti-aquaporin 4 antibodies, B cells, Th1 cells, Th2 cells, Th17 cells, or others?
    Kira JI
    Mult Scler; 2017 Aug; 23(9):1300-1302. PubMed ID: 28391741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Relapse After Cessation of Immunosuppressive Therapy in a Patient With Neuromyelitis Optica Spectrum Disorder.
    Hyun JW; Kim G; Kim Y; Jeong IH; Kim SH; Kim HJ
    Neurologist; 2016 Nov; 21(6):97-98. PubMed ID: 27801768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
    Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of neuromyelitis optica spectrum disorder developing a fulminant course with multiple white-matter lesions following fingolimod treatment].
    Izaki S; Narukawa S; Kubota A; Mitsui T; Fukaura H; Nomura K
    Rinsho Shinkeigaku; 2013; 53(7):513-7. PubMed ID: 23892961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic options in neuromyelitis optica spectrum disorders.
    Kitley J; Palace J
    Expert Rev Neurother; 2016; 16(3):319-29. PubMed ID: 26840802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorder.
    Yoshii F; Moriya Y; Ohnuki T; Ryo M; Takahashi W
    Mult Scler Relat Disord; 2016 May; 7():53-7. PubMed ID: 27237757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders.
    Fragomeni MO; Bichuetti DB; Oliveira EML
    Mult Scler Relat Disord; 2018 Oct; 25():138-142. PubMed ID: 30075406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis optica spectrum disorder mimicking multiple sclerosis.
    van Rooij LC; Wattjes MP; de Jong BA; van Oosten BW
    Mult Scler Relat Disord; 2017 Oct; 17():54-56. PubMed ID: 29055475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
    Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
    JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis and neuromyelitis optica spectrum disorder testing and treatment availability in Latin America.
    Rojas JI; Gracia F; Patrucco L; Alonso R; Carnero Contentti E; Cristiano E
    Neurol Res; 2021 Dec; 43(12):1081-1086. PubMed ID: 34240685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of venous thromboembolism in neuromyelitis optica patients hospitalized for acute relapse.
    Farber RS; Gross R; Zakin E; Fabian M
    Mult Scler; 2017 Jun; 23(7):988-994. PubMed ID: 27672136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Severe rebound after withdrawal of fingolimod in a patient with neuromyelitis optica spectrum disorder.
    Lin W; Chou CH; Yang FC; Tsai CK; Lin YK; Sung YF
    Front Immunol; 2023; 14():1115120. PubMed ID: 37122715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.
    Ayzenberg I; Schöllhammer J; Hoepner R; Hellwig K; Ringelstein M; Aktas O; Kümpfel T; Krumbholz M; Trebst C; Paul F; Pache F; Obermann M; Zeltner L; Schwab M; Berthele A; Jarius S; Kleiter I;
    J Neurol; 2016 Mar; 263(3):575-82. PubMed ID: 26810718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
    Kim SM; Waters P; Woodhall M; Kim JY; Kim JE; Yang JW; Kim JS; Sung JJ; Park KS; Lee KW
    Mult Scler; 2013 Jul; 19(8):1060-7. PubMed ID: 23329699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythema nodosum in a patient with multiple sclerosis on dimethyl fumarate.
    Algahtani H; Shirah B; Marghalani S; Algarni A
    Mult Scler Relat Disord; 2019 Feb; 28():155-158. PubMed ID: 30597324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders.
    Zalewski NL; Morris PP; Weinshenker BG; Lucchinetti CF; Guo Y; Pittock SJ; Krecke KN; Kaufmann TJ; Wingerchuk DM; Kumar N; Flanagan EP
    J Neurol Neurosurg Psychiatry; 2017 Mar; 88(3):218-225. PubMed ID: 27913626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.